S. Benhamou, W. Lee, A. Alexandrie, P. Boffetta, C. Bouchardy et al., Meta- and pooled analyses of the effects of glutathione S-transferase M1 polymorphisms and smoking on lung cancer risk, Carcinogenesis, vol.23, issue.8, pp.231343-50, 2002.
DOI : 10.1093/carcin/23.8.1343

S. Benhamou and A. Sarasin, ERCC2 /XPD Gene Polymorphisms and Lung Cancer: A HuGE Review, American Journal of Epidemiology, vol.161, issue.1, pp.1-14, 2005.
DOI : 10.1093/aje/kwi018

P. Brennan, S. Lewis, M. Hashibe, D. Bell, P. Boffetta et al., Pooled Analysis of Alcohol Dehydrogenase Genotypes and Head and Neck Cancer: A HuGE Review, American Journal of Epidemiology, vol.159, issue.1, pp.1-16, 2004.
DOI : 10.1093/aje/kwh003

R. Cartwright, R. Glashan, H. Rogers, R. Ahmad, D. Barham-hall et al., Role of Nacetyltransferase phenotypes in bladder carcinogenesis: a pharmacogenetic epidemiological approach to bladder cancer, Lancet, issue.28303, pp.842-847, 1982.

V. Chaudru, K. Laud, M. Avril, A. Minière, A. Chompret et al., Melanocortin-1 Receptor (MC1R) Gene Variants and Dysplastic Nevi Modify Penetrance of CDKN2A Mutations in French Melanoma-Prone Pedigrees, Cancer Epidemiology Biomarkers & Prevention, vol.14, issue.10, pp.2384-90, 2005.
DOI : 10.1158/1055-9965.EPI-04-0777

L. Engel, E. Taioli, R. Pfeiffer, M. Garcia-closas, P. Marcus et al., Pooled Analysis and Meta-analysis of Glutathione S-Transferase M1 and Bladder Cancer: A HuGE Review, American Journal of Epidemiology, vol.156, issue.2, pp.95-109, 2002.
DOI : 10.1093/aje/kwf018

M. García-closas, N. Malats, D. Silverman, M. Dosemeci, M. Kogevinas et al., NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses, The Lancet, vol.366, issue.9486, pp.366649-59, 2005.
DOI : 10.1016/S0140-6736(05)67137-1

L. Gaspari, D. Marinelli, and E. Taioli, International collaborative study on genetic susceptibility to environmental carcinogens (GSEC): an update, International Journal of Hygiene and Environmental Health, vol.204, issue.1, pp.39-42, 2001.
DOI : 10.1078/1438-4639-00070

M. Hashibe, P. Boffetta, D. Zaridze, O. Shangina, N. Szeszenia-dabrowska et al., Evidence for an Important Role of Alcohol- and Aldehyde-Metabolizing Genes in Cancers of the Upper Aerodigestive Tract, Cancer Epidemiology Biomarkers & Prevention, vol.15, issue.4, pp.696-703, 2006.
DOI : 10.1158/1055-9965.EPI-05-0710

M. Hashibe, P. Brennan, R. Strange, R. Bhisey, I. Cascorbi et al., Meta-and pooled analyses of GSTM1, GSTT1, GSTP1, and CYP1A1 genotypes and risk of head and neck cancer, Cancer Epidemiol Biomarkers Prev, vol.12, issue.12, pp.1509-1526, 2003.

N. Hayward, Genetics of melanoma predisposition, Oncogene, vol.22, issue.20, pp.3053-62, 2003.
DOI : 10.1038/sj.onc.1206445

R. Hung, J. Hall, P. Brennan, and P. Boffetta, Genetic Polymorphisms in the Base Excision Repair Pathway and Cancer Risk: A HuGE Review, American Journal of Epidemiology, vol.162, issue.10, pp.925-967, 2005.
DOI : 10.1093/aje/kwi318

M. Sundberg, M. Kihara, A. Rannug, D. Ryberg, I. Stücker et al., Pooled analysis of the CYP1A1 exon 7 polymorphism and lung cancer (United States), Cancer Causes Control, vol.14, issue.4, pp.339-385, 2003.

M. Manuguerra, F. Saletta, M. Karagas, M. Berwick, F. Veglia et al., XRCC3 and XPD/ERCC2 Single Nucleotide Polymorphisms and the Risk of Cancer: A HuGE Review, American Journal of Epidemiology, vol.164, issue.4, pp.297-302, 2006.
DOI : 10.1093/aje/kwj189

S. Raimondi, P. Boffetta, S. Anttila, J. Bröckmoller, D. Butkiewicz et al., Metabolic gene polymorphisms and lung cancer risk in non-smokers, Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol.592, issue.1-2, pp.45-57, 2005.
DOI : 10.1016/j.mrfmmm.2005.06.002

P. Vineis, D. Marinelli, H. Autrup, J. Brockmoller, I. Cascorbi et al., Current smoking, occupation, N-acetyltransferase-2 and bladder cancer: a pooled analysis of genotypebased studies, Cancer Epidemiol Biomarkers Prev, vol.10, issue.12, pp.1249-52, 2001.

P. Vineis, F. Veglia, S. Anttila, S. Benhamou, M. Clapper et al., CYP1A1, GSTM1 and GSTT1 polymorphisms and lung cancer: a pooled analysis of gene???gene interactions, Biomarkers, vol.5, issue.3, pp.298-305, 2004.
DOI : 10.1097/00008571-200010000-00005

P. Vineis, F. Veglia, S. Benhamou, D. Butkiewicz, I. Cascorbi et al., CYP1A1 T3801 C polymorphism and lung cancer: A pooled analysis of 2,451 cases and 3,358 controls, CYP1A1 T3801 C polymorphism and lung cancer: a pooled analysis of 2451 cases and 3358 controls, pp.650-657, 2003.
DOI : 10.1002/ijc.10995

Z. Ye, H. Song, J. Higgins, P. Pharoah, and J. Danesh, Five Glutathione S-Transferase Gene Variants in 23,452 Cases of Lung Cancer and 30,397 Controls: Meta-Analysis of 130 Studies, PLoS Medicine, vol.328, issue.4, p.91, 2006.
DOI : 10.1371/journal.pmed.0030091.st001